脱毛症治療の世界市場レポート 2025年

脱毛症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.7％で132億2,000万米ドルに成長します。予測期間中の成長は、非侵襲的治療法の採用の増加、個別化医療への需要の増加、メンタルヘルスと自尊心への注目の高まり、脱毛の原因と治療法に関する消費者の意識の高まり、脱毛症治療の臨床検査の増加に起因すると考えられます。予測期間における主要動向としては、幹細胞を用いた毛髪再生の発展、多血小板血漿（多血小板血漿）療法の利用、自己免疫関連脱毛症に対するJAK阻害剤の開発、レーザー毛髪治療の革新、発毛を促進する装着型デバイスの出現などが挙げられます。

脱毛の有病率の増加は、脱毛症治療市場の成長を加速させると予想されます。脱毛とは、頭皮や身体の他の部位から部分的または完全に毛髪が失われる状態を指します。抜け毛の有病率は、ストレスレベルの上昇などの要因によって上昇しており、これが正常な毛髪成長サイクルを乱し、毛細血管拡大症（telogen effluvium）などの状態を引き起こし、過剰な抜け毛をもたらす可能性があります。抜け毛を管理し回復させるための効果的な解決策を求める人が増えるにつれ、高度で利用しやすい脱毛症治療への需要が高まっています。例えば、2024年10月、米国を拠点とする皮膚科専門の医師会である米国皮膚科学会は、男性5,000万人、女性3,000万人を含む8,000万人の米国人が脱毛の影響を受けていると報告しました。このように、抜け毛の有病率の増加が脱毛症治療市場の拡大に拍車をかけています。

脱毛症治療市場の主要企業は、経口低分子ヤヌスキナーゼ（JAK）阻害剤などの革新的なソリューションの開発に注力しており、治療効果の改善、発毛の促進、重症または抵抗性の円形脱毛症患者に対する標的治療の提供を目指しています。経口低分子JAK阻害剤は、1つ以上のヤヌスキナーゼ酵素（JAK1、JAK2、JAK3、TYK2）の活性を阻害するように設計された標的医薬品の一種です。例えば、2024年7月、インドの製薬会社であるサン・ファーマシューティカルインダストリーズ社は、経口JAK阻害剤LEQSELVIについて、成人の重症円形脱毛症の治療として米国食品医薬品局（FDA）から承認を取得しました。LEQSELVIはJAK1とJAK2酵素を選択的に阻害し、この自己免疫疾患における毛包に対する免疫系の攻撃に重要な役割を果たします。推奨用量は、1回8mgを1日2回、食事の有無にかかわらず経口投与します。今回のFDAの承認により、身体的、精神的、社会的に重大な影響を及ぼしうる円形脱毛症に苦しむ人々にとって、新たな効果的な治療オプションが導入されることになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の脱毛症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の脱毛症治療市場：成長率分析
• 世界の脱毛症治療市場の実績：規模と成長、2019～2024年
• 世界の脱毛症治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の脱毛症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の脱毛症治療市場：剤形別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬剤療法
• 毛髪移植サービス
• 低出力レーザー療法
• 世界の脱毛症治療市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所
• 注射剤
• 経口
• 世界の脱毛症治療市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• 円形脱毛症
• 全頭脱毛症
• 汎発性脱毛症
• 髭脱毛症
• 化学療法誘発性脱毛症
• その他
• 世界の脱毛症治療市場：性別、実績と予測、2019～2024年、2024～2029年、2034年
• 男性
• 女性
• 世界の脱毛症治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院と医院
• 皮膚科クリニック
• その他
• 世界の脱毛症治療市場、薬剤療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 局所薬
• 経口薬
• 注射による治療
• 免疫抑制剤
• ヤヌスキナーゼ阻害剤
• 世界の脱毛症治療市場、毛髪移植サービスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 毛包単位移植（FUT）
• 毛包単位抽出（FUE）
• ロボットによる毛髪移植
• 直接毛髪移植（DHI）
• 世界の脱毛症治療市場、低出力レーザー療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• レーザーヘルメット
• レーザーコーム
• レーザーキャップ
• 院内レーザー装置

第7章 地域別・国別分析

• 世界の脱毛症治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の脱毛症治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脱毛症治療市場：競合情勢
• 脱毛症治療市場：企業プロファイル
  • Pfizer Inc.
  • Eli Lilly and Company
  • Sun Pharmaceutical Industries Inc.
  • Incyte Corporation
  • Hims & Hers Health Inc.

第31章 その他の大手企業と革新的企業

• Bosley Inc.
• Hair Club Co.
• Dermavant Sciences Inc.
• Histogen Inc.
• Capillus llc
• Aclaris Therapeutics Inc.
• Nutrafol
• Alvi Armani Co
• Rogaine
• Theradome Inc.
• Viviscal Ltd
• Arena Pharmaceuticals Ltd
• Cassiopea SA
• Follica Inc.
• RepliCel Life Sciences Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 脱毛症治療市場、2029年：新たな機会を提供する国
• 脱毛症治療市場、2029年：新たな機会を提供するセグメント
• 脱毛症治療市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Alopecia treatment encompasses a range of medical and cosmetic methods aimed at managing and reducing hair loss, and in some cases, encouraging hair regrowth. Treatment options include topical solutions including minoxidil, oral medications, steroid injections, and therapies targeting the immune system. The choice of treatment depends on the type and severity of alopecia.

The primary treatment forms in the alopecia market include drug therapy, hair transplant services, and low-level laser therapy. Drug therapies include both prescription and over-the-counter pharmaceutical treatments that address hair loss through various mechanisms. These treatments can be administered through different routes, such as topical applications and injections, and are used for conditions including alopecia areata, alopecia totalis, alopecia universalis, alopecia barbae, chemotherapy-induced alopecia, and others. The treatments are available for both males and females. Key end users of these treatments include hospitals, physician offices, dermatology clinics, and other healthcare facilities.

The alopecia treatment market research report is one of a series of new reports from The Business Research Company that provides alopecia treatment market statistics, including alopecia treatment industry global market size, regional shares, competitors with a alopecia treatment market share, detailed alopecia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the alopecia treatment industry. The alopecia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alopecia treatment market size has grown strongly in recent years. It will grow from $9.56 billion in 2024 to $10.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historical period can be attributed to the rising prevalence of alopecia, an aging population, hormonal changes, genetic factors, increased awareness of hair loss treatments, expansion of the cosmetic and dermatology industries, and better access to healthcare.

The alopecia treatment market size is expected to see strong growth in the next few years. It will grow to $13.22 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth during the forecast period can be attributed to the rising adoption of non-invasive treatments, increasing demand for personalized medicine, a growing focus on mental health and self-esteem, greater consumer awareness of hair loss causes and treatments, and a rise in clinical trials for alopecia therapies. Key trends in the forecast period include advancements in stem cell-based hair regeneration, the use of platelet-rich plasma (PRP) therapy, the development of JAK inhibitors for autoimmune-related alopecia, innovations in laser hair therapy, and the emergence of wearable devices for stimulating hair growth.

The growing prevalence of hair loss is expected to accelerate the growth of the alopecia treatment market. Hair loss refers to the condition in which an individual experiences partial or complete hair loss from the scalp or other areas of the body. The prevalence of hair loss is rising due to factors such as elevated stress levels, which can disrupt the normal hair growth cycle and trigger conditions including telogen effluvium, resulting in excessive hair shedding. As more individuals seek effective solutions to manage and reverse hair loss, the demand for advanced and accessible alopecia treatments is increasing. For example, in October 2024, the American Academy of Dermatology, a U.S.-based professional medical association specializing in dermatology, reported that 80 million Americans were affected by hair loss, including 50 million men and 30 million women. Thus, the growing prevalence of hair loss is fueling the expansion of the alopecia treatment market.

Leading companies in the alopecia treatment market are focusing on developing innovative solutions, such as oral small-molecule Janus kinase (JAK) inhibitors, to improve treatment efficacy, accelerate hair regrowth, and provide targeted therapy for patients with severe or resistant forms of alopecia areata. Oral small-molecule JAK inhibitors are a class of targeted pharmaceutical drugs designed to block the activity of one or more Janus kinase enzymes (JAK1, JAK2, JAK3, and TYK2). For example, in July 2024, Sun Pharmaceutical Industries Limited, a pharmaceutical company based in India, received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI, an oral JAK inhibitor, for the treatment of adults with severe alopecia areata. LEQSELVI selectively inhibits the JAK1 and JAK2 enzymes, which play a key role in the immune system's attack on hair follicles in this autoimmune disorder. The recommended dosage is 8 mg orally twice daily, with or without food. This FDA approval introduces a new, effective treatment option for individuals suffering from alopecia areata, a condition that can have significant physical, emotional, and social effects.

In February 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. This acquisition provided Sun Pharma with access to deuruxolitinib, a late-stage oral JAK inhibitor being developed for the treatment of alopecia areata. The move strengthens Sun Pharma's dermatology portfolio and bolsters its position in the global specialty pharmaceuticals market. Concert Pharmaceuticals Inc. is a US-based biopharmaceutical company, specializing in developing novel small-molecule drugs for treating alopecia areata.

Major players in the alopecia treatment market are Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Inc., Incyte Corporation, Hims & Hers Health Inc., Bosley Inc., Hair Club Co., Dermavant Sciences Inc., Histogen Inc., Capillus llc, Aclaris Therapeutics Inc., Nutrafol, Alvi Armani Co, Rogaine, Theradome Inc., Viviscal Ltd, Arena Pharmaceuticals Ltd, Cassiopea SA, Follica Inc., RepliCel Life Sciences Inc., HairClone Ltd, Revian Inc., and Nioxin.

North America was the largest region in the alopecia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in alopecia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the alopecia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alopecia treatment market consists of revenues earned by entities providing a wide range of services, such as medical consultations, hair restoration procedures, topical and oral medications, laser therapies, and personalized treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia treatment market also includes sales of products such as topical solutions, oral medications, hair growth shampoos, and laser therapy devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alopecia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alopecia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alopecia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alopecia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Dosage Form: Drug Therapy; Hair Transplant Services; Low-Level Laser Therapy
• 2) By Route of Administration: Topical; Injectable; Oral
• 3) By Indication: Alopecia Areata; Alopecia Totalis; Alopecia Universalis; Alopecia Barbae; Chemotherapy Induced Alopecia; Other Indications
• 4) By Gender Type: Male; Female
• 5) By End User: Hospitals And Physicians Offices; Dermatology Clinics; Other End Users
• Subsegments:
• 1) By Drug Therapy: Topical Solutions; Oral Medications; Injectable Treatments; Immunosuppressants; Janus Kinase Inhibitors
• 2) By Hair Transplant Services: Follicular Unit Transplantation (FUT); Follicular Unit Extraction (FUE); Robotic Hair Transplantation; Direct Hair Implantation (DHI)
• 3) By Low-Level Laser Therapy (LLLT): Laser Helmets; Laser Combs; Laser Caps; In-Clinic Laser Devices
• Companies Mentioned: Pfizer Inc.; Eli Lilly and Company; Sun Pharmaceutical Industries Inc.; Incyte Corporation; Hims & Hers Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Alopecia Treatment Market Characteristics

3. Alopecia Treatment Market Trends And Strategies

4. Alopecia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Alopecia Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Alopecia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Alopecia Treatment Market Growth Rate Analysis
• 5.4. Global Alopecia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Alopecia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Alopecia Treatment Total Addressable Market (TAM)

6. Alopecia Treatment Market Segmentation

• 6.1. Global Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Therapy
• Hair Transplant Services
• Low-Level Laser Therapy
• 6.2. Global Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical
• Injectable
• Oral
• 6.3. Global Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis
• Alopecia Barbae
• Chemotherapy Induced Alopecia
• Other Indications
• 6.4. Global Alopecia Treatment Market, Segmentation By Gender Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Male
• Female
• 6.5. Global Alopecia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Physicians Offices
• Dermatology Clinics
• Other End Users
• 6.6. Global Alopecia Treatment Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Solutions
• Oral Medications
• Injectable Treatments
• Immunosuppressants
• Janus Kinase Inhibitors
• 6.7. Global Alopecia Treatment Market, Sub-Segmentation Of Hair Transplant Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Follicular Unit Transplantation (FUT)
• Follicular Unit Extraction (FUE)
• Robotic Hair Transplantation
• Direct Hair Implantation (DHI)
• 6.8. Global Alopecia Treatment Market, Sub-Segmentation Of Low-Level Laser Therapy (LLLT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laser Helmets
• Laser Combs
• Laser Caps
• In-Clinic Laser Devices

7. Alopecia Treatment Market Regional And Country Analysis

• 7.1. Global Alopecia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Alopecia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Alopecia Treatment Market

• 8.1. Asia-Pacific Alopecia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Alopecia Treatment Market

• 9.1. China Alopecia Treatment Market Overview
• 9.2. China Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Alopecia Treatment Market

• 10.1. India Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Alopecia Treatment Market

• 11.1. Japan Alopecia Treatment Market Overview
• 11.2. Japan Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Alopecia Treatment Market

• 12.1. Australia Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Alopecia Treatment Market

• 13.1. Indonesia Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Alopecia Treatment Market

• 14.1. South Korea Alopecia Treatment Market Overview
• 14.2. South Korea Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Alopecia Treatment Market

• 15.1. Western Europe Alopecia Treatment Market Overview
• 15.2. Western Europe Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Alopecia Treatment Market

• 16.1. UK Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Alopecia Treatment Market

• 17.1. Germany Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Alopecia Treatment Market

• 18.1. France Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Alopecia Treatment Market

• 19.1. Italy Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Alopecia Treatment Market

• 20.1. Spain Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Alopecia Treatment Market

• 21.1. Eastern Europe Alopecia Treatment Market Overview
• 21.2. Eastern Europe Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Alopecia Treatment Market

• 22.1. Russia Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Alopecia Treatment Market

• 23.1. North America Alopecia Treatment Market Overview
• 23.2. North America Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Alopecia Treatment Market

• 24.1. USA Alopecia Treatment Market Overview
• 24.2. USA Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Alopecia Treatment Market

• 25.1. Canada Alopecia Treatment Market Overview
• 25.2. Canada Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Alopecia Treatment Market

• 26.1. South America Alopecia Treatment Market Overview
• 26.2. South America Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Alopecia Treatment Market

• 27.1. Brazil Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Alopecia Treatment Market

• 28.1. Middle East Alopecia Treatment Market Overview
• 28.2. Middle East Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Alopecia Treatment Market

• 29.1. Africa Alopecia Treatment Market Overview
• 29.2. Africa Alopecia Treatment Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Alopecia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Alopecia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Alopecia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Alopecia Treatment Market Competitive Landscape
• 30.2. Alopecia Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sun Pharmaceutical Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Incyte Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hims & Hers Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Alopecia Treatment Market Other Major And Innovative Companies

• 31.1. Bosley Inc.
• 31.2. Hair Club Co.
• 31.3. Dermavant Sciences Inc.
• 31.4. Histogen Inc.
• 31.5. Capillus llc
• 31.6. Aclaris Therapeutics Inc.
• 31.7. Nutrafol
• 31.8. Alvi Armani Co
• 31.9. Rogaine
• 31.10. Theradome Inc.
• 31.11. Viviscal Ltd
• 31.12. Arena Pharmaceuticals Ltd
• 31.13. Cassiopea SA
• 31.14. Follica Inc.
• 31.15. RepliCel Life Sciences Inc.

32. Global Alopecia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alopecia Treatment Market

34. Recent Developments In The Alopecia Treatment Market

35. Alopecia Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Alopecia Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Alopecia Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Alopecia Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer